Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Clinical trial NCT07332156 · COMPLETED

Trial details

NCT number: NCT07332156
Sponsor: Samsung Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes COPD (Chronic Obstructive Pulmonary Disease)Lung Cancer (Diagnosis)

Start date: 2009-01-01
Primary completion: 2023-12-31
Enrollment: 21692

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.